Kristina Gemzell-Danielsson

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Misoprostol: first-line therapy for incomplete miscarriage in the developing world
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden
    BJOG 114:1337-9. 2007
  2. ncbi Emergency contraception -- mechanisms of action
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Contraception 87:300-8. 2013
  3. ncbi Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, 17176 Stockholm, Sweden
    Contraception 86:631-8. 2012
  4. ncbi A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena
    Kristina Gemzell-Danielsson
    Division of Obstetrics and Gynecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 97:616-22.e1-3. 2012
  5. ncbi Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institute Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 90:1177-88. 2011
  6. ncbi Comprehensive counseling about combined hormonal contraceptives changes the choice of contraceptive methods: results of the CHOICE program in Sweden
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 90:869-77. 2011
  7. ncbi [Valuable drug for women in poor countries scraped--why?]
    Kristina Gemzell Danielsson
    Karolinska Universitetssjukhuset, Solna
    Lakartidningen 103:3901-2. 2006
  8. ncbi Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management
    Kristina Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Reprod Health Matters 16:162-72. 2008
  9. ncbi Mechanism of action of emergency contraception
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Contraception 82:404-9. 2010
  10. ncbi Studies on uterine contractility following mifepristone and various routes of misoprostol
    Kristina Gemzell-Danielsson
    Department of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institute, SE 171 76 Stockholm, Sweden
    Contraception 74:31-5. 2006

Collaborators

Detail Information

Publications57

  1. ncbi Misoprostol: first-line therapy for incomplete miscarriage in the developing world
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, Stockholm, Sweden
    BJOG 114:1337-9. 2007
  2. ncbi Emergency contraception -- mechanisms of action
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Contraception 87:300-8. 2013
    ..An additional effect on the endometrium as occurs for the Cu-IUD, but not for the hormonal alternatives, seems to increase the efficacy of the method...
  3. ncbi Use of contraceptive methods and contraceptive recommendations among health care providers actively involved in contraceptive counseling -- results of an international survey in 10 countries
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, 17176 Stockholm, Sweden
    Contraception 86:631-8. 2012
    ....
  4. ncbi A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena
    Kristina Gemzell-Danielsson
    Division of Obstetrics and Gynecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 97:616-22.e1-3. 2012
    ..To identify an appropriate dose for a new contraceptive levonorgestrel intrauterine system (LNG-IUS)...
  5. ncbi Recent developments in the clinical use of the levonorgestrel-releasing intrauterine system
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institute Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 90:1177-88. 2011
    ..In treatment of heavy menstrual bleeding, the LNG-IUS appears to be one of the most effective and cost-effective methods...
  6. ncbi Comprehensive counseling about combined hormonal contraceptives changes the choice of contraceptive methods: results of the CHOICE program in Sweden
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 90:869-77. 2011
    ..To study the influence of counseling on women's contraceptive decisions...
  7. ncbi [Valuable drug for women in poor countries scraped--why?]
    Kristina Gemzell Danielsson
    Karolinska Universitetssjukhuset, Solna
    Lakartidningen 103:3901-2. 2006
  8. ncbi Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management
    Kristina Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Reprod Health Matters 16:162-72. 2008
    ..Future studies should focus on improving pain management, the treatment of women with failed medical abortion after 24 hours, and the safety of medical abortion regimens in women with a previous caesarean section or uterine scar...
  9. ncbi Mechanism of action of emergency contraception
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, S 171 76 Stockholm, Sweden
    Contraception 82:404-9. 2010
    ..LNG-EC has no effect on endometrial development or function. In an in vitro model, it was demonstrated that LNG did not interfere with blastocyst function or implantation...
  10. ncbi Studies on uterine contractility following mifepristone and various routes of misoprostol
    Kristina Gemzell-Danielsson
    Department of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institute, SE 171 76 Stockholm, Sweden
    Contraception 74:31-5. 2006
    ..Recently, a new oral slow-release preparation of misoprostol has been studied. Future studies will show whether prostaglandin analogues with a prolonged effect on the myometrium may further improve the regimens for medical abortion...
  11. ncbi Teaching pelvic examination technique using professional patients: a controlled study evaluating students' skills
    Kjell Wånggren
    Department of Women s and Children s Health, Uppsala University, Akademiska Hospital, Uppsala, Sweden
    Acta Obstet Gynecol Scand 89:1298-303. 2010
    ..To compare the skills in pelvic examination technique between students who have had training with professional patients and a control group of students trained using clinical patients...
  12. ncbi Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone
    Xiaoxi Sun
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital/Institute, S-171 76, Stockholm, Sweden
    Contraception 67:319-26. 2003
    ..These results further support the hypothesis that the contraceptive effect of mifepristone when given postovulatory is primarily due to alteration of the peri-implantation milieu influencing endometrial receptivity...
  13. ncbi Action of mifepristone on the expression of insulin-like growth factor binding protein-1 mRNA and protein during the early luteal phase in the human oviduct
    Xiaoyan Qiu
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
    Fertil Steril 80:776-82. 2003
    ....
  14. ncbi Measurement of luminal nitric oxide in the uterine cavity using a silicon balloon catheter
    Angelos Sioutas
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Nitric Oxide 24:213-6. 2011
    ..The levels of nitric oxide are increased in women diagnosed with pelvic inflammatory disease already after an incubation time of 2 min...
  15. ncbi Expression of aquaporin-1 in endometrial blood vessels in menorrhagia
    Miriam Mints
    Department of Clinical Science, Division of Obstetrics and Gynecology, Karolinska University Hospital Huddinge, Karolinska Institutet, S 14186 Stockholm, Sweden
    Int J Mol Med 19:407-11. 2007
    ..006). Thus, the deregulation of aquaporin-1 in menorrhagia may be involved in abnormal endometrial vascular growth and permeability...
  16. ncbi Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone
    Caroline Arvidsson
    Department of Obstetrics and Gynecology, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
    Eur J Obstet Gynecol Reprod Biol 123:87-91. 2005
    ..CONCLUSION: A majority of women prefer oral administration of misoprostol in early medical abortion...
  17. ncbi Aquaporin 1 is expressed in the human endometrium during normal cycle and increases after mifepristone treatment
    Anna Hildenbrand
    Division of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Int J Mol Med 22:49-53. 2008
    ..The presence of AQP1 was also confirmed using RT-PCR. The changes in AQP1 expression could contribute to the reduced bleeding seen following mifepristone treatment and could be an effect of either antagonizing progesterone or cortisol...
  18. ncbi Medical students learning the pelvic examination: evaluation of a clinical patient model
    Kjell Wånggren
    Department of Women s and Children s Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 89:1304-9. 2010
    ..To evaluate a clinical patient (CP) model for training in pelvic examination...
  19. ncbi Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model
    Chun Xia Meng
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 91:256-64. 2009
    ..To investigate the effect of levonorgestrel and mifepristone on the expression of endometrial receptivity markers in a three-dimensional endometrial construct...
  20. ncbi Medical abortion in lactating women--low levels of mifepristone in breast milk
    Ingrid Sääv
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 89:618-22. 2010
    ..In addition, serum samples were collected on day 3 (n = 4). Main outcome measures. The levels of mifepristone, quantified using radioimmunoassay...
  21. ncbi Expression of aquaporin 2 in human endometrium
    Anna Hildenbrand
    Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Fertil Steril 86:1452-8. 2006
    ..To study the expression of aquaporin-2 (AQP2) in human endometrium...
  22. ncbi Effects of mifepristone on expression of endothelial nitric oxide synthase in human endometrium during the implantation phase
    Xiaoxi Sun
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital, Stockholm, Sweden
    Fertil Steril 80:1454-60. 2003
    ..The results support a role of epithelial eNOS in human endometrial receptivity...
  23. ncbi The effect of orally and vaginally administered misoprostol on inflammatory mediators and cervical ripening during early pregnancy
    Annette Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Institute, S-171 76 Stockholm, Sweden
    Contraception 72:33-9. 2005
    ....
  24. ncbi Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicine
    Rebecca Gomperts
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 91:226-31. 2012
    ..Analysis of factors influencing surgical intervention rate after home medical termination of pregnancy (TOP) by women in countries without access to safe services using the telemedical service 'Women on Web'...
  25. ncbi Intrauterine nitric oxide in pelvic inflammatory disease
    Angelos Sioutas
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Fertil Steril 89:948-52. 2008
    ..To measure nitric oxide gas directly in the uterus of healthy women and patients with suspected pelvic inflammatory disease...
  26. ncbi Effect of emergency contraception with levonorgestrel or mifepristone on ovarian function
    Lena Marions
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Hospital Institute, 17176 Stockholm, Sweden
    Contraception 69:373-7. 2004
    ..This study indicates that, when used for EC, LNG or MIF administered prior to ovulation acts through an impaired ovulatory process and luteal function...
  27. ncbi Expression of heparin-binding epidermal growth factor-like growth factor and its receptors in the human fallopian tube and endometrium after treatment with mifepristone
    Xiao Xi Sun
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Fertil Steril 85:171-8. 2006
    ..CONCLUSION(S): Treatment with mifepristone has a limited effect on HB-EGF and its receptors in the fallopian tube, while the increase in HER1 and HER4 in the endometrium probably reflects defective endometrial maturation...
  28. ncbi Early versus delayed insertion of intrauterine contraception after medical abortion - a randomized controlled trial
    Ingrid Sääv
    Department of Women s and Children s Health, Division of Obstetrics and Gynaecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    PLoS ONE 7:e48948. 2012
    ..Intrauterine contraceptives (IUC) provide highly effective, reversible, long-acting contraception. However, the effects of timing of IUC insertion after medical abortion are not known...
  29. ncbi Effect of letrozole on uterine tonus and contractility: a randomized controlled trial
    Helena Kopp Kallner
    Division of Obstetrics and Gynaecology, Department of Women s and Children s Health, Karolinska Institutet Karolinska University Hospital, 171 77 Stockholm, Sweden
    Contraception 86:419-24. 2012
    ..It has been shown to increase efficacy in medical abortion when used with misoprostol. This study investigated if letrozole acts as an abortifacient due to a synergistic effect with misoprostol on uterine contractility...
  30. ncbi Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion
    Helena Kopp Kallner
    Division of Obstetrics and Gynaecology, Department of Woman and Child Health, Karolinska Institutet Karolinska University Hospital, 171 77 Stockholm, Sweden
    Contraception 85:394-7. 2012
    ..The objective of this study was therefore to assess factors affecting acceptability and experience of home use of misoprostol for medical abortion up to 63 days' gestation...
  31. ncbi Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model
    P G L Lalitkumar
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, S 171 76, Stockholm, Sweden
    Hum Reprod 22:3031-7. 2007
    ..This study investigates the effect of levonorgestrel and mifepristone on attachment of human embryos to an in vitro endometrial construct...
  32. ncbi Perceptions of contraception, non-protection and induced abortion among a sample of urban Swedish teenage girls: focus group discussions
    Caroline Thorsén
    Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden
    Eur J Contracept Reprod Health Care 11:302-9. 2006
    ..To explore the attitudes of teenage girls towards contraception and induced abortion in order to better understand underlying reasons for non-protection...
  33. ncbi Mechanisms of action of mifepristone when used for emergency contraception
    Kristina Gemzell-Danielsson
    Department of Woman and Child Health, Division for Obstetrics and Gynecology, Karolinska Hospital Institute, S 171 76, Stockholm, Sweden
    Contraception 68:471-6. 2003
    ....
  34. ncbi Expressions of steroid receptors and Ki67 in first-trimester decidua and chorionic villi exposed to levonorgestrel used for emergency contraception
    Chun Xia Meng
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    Fertil Steril 91:1420-3. 2009
    ....
  35. ncbi Acceptability of home-use of misoprostol in medical abortion
    Christian Fiala
    Division for Obstetrics and Gynaecology, Department of Woman and Child Health, Karolinska Hospital/Institute, S-171 76 Stockholm, Sweden
    Contraception 70:387-92. 2004
    ..Women should be offered this choice to allow more flexibility and privacy in their abortions...
  36. ncbi Emergency contraception
    P G L Lalitkumar
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet WHO Collaborating Center, Karolinska University Hospital, Stockholm, Sweden
    Best Pract Res Clin Endocrinol Metab 27:91-101. 2013
    ..To increase efficacy future studies should focus on EC methods that target the endometrium...
  37. ncbi An historical overview of second trimester abortion methods
    Marc Bygdeman
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
    Reprod Health Matters 16:196-204. 2008
    ....
  38. ncbi Teaching medical students gynaecological examination using professional patients-evaluation of students' skills and feelings
    Kjell Wånggren
    Department of Woman and Child Health, Division of Obstetrics and Gynaecology, Karolinska Hospital Institute, Stockholm, Sweden
    Med Teach 27:130-5. 2005
    ..It is strongly recommended that this type of programme with professional patients should be used for teaching gynaecological examination techniques to medical students...
  39. ncbi Measurement of nitric oxide in the vagina
    Angelos Sioutas
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Acta Obstet Gynecol Scand 87:1055-9. 2008
    ..The objective of this study is to measure NO gas directly in the vaginal lumen of healthy women and in patients with vaginitis...
  40. ncbi The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium
    Xiaoyan Qiu
    Division of Obstetrics and Gynecology, Department of Woman and Child Health, Karolinska Hospital, S-171 76 Stockholm, Sweden
    Mol Hum Reprod 8:998-1004. 2002
    ..Our findings provide further insight into the regulation of IGFBP-1 and prolactin by PR in the human endometrium in vivo...
  41. ncbi Emergency contraception: potential role of ulipristal acetate
    Kristina Gemzell-Danielsson
    Department of Women s and Children s Health, Division of Obstetrics and Gynecology, Karolinska Institutet, Stockholm, Sweden
    Int J Womens Health 2:53-61. 2010
    ....
  42. ncbi Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS)
    Oskari Heikinheimo
    Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
    Acta Obstet Gynecol Scand 91:3-9. 2012
    ..Further studies are needed to examine the full potential of the LNG-IUS in such common clinical situations...
  43. ncbi Emergency contraception with mifepristone and levonorgestrel: mechanism of action
    Lena Marions
    Department of Women and Child Health, Karolinska Hospital, Stockholm, Sweden
    Obstet Gynecol 100:65-71. 2002
    ..To study the effect of mifepristone and levonorgestrel on ovarian function and endometrial development in doses effective as emergency contraception...
  44. ncbi Effects of misoprostol on uterine contractility following different routes of administration
    A Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute/Hospital, S-171 76 Stockholm, Sweden
    Hum Reprod 19:81-4. 2004
    ..CONCLUSIONS: Based on recording of uterine activity, sublingual misoprostol acts as rapidly as oral treatment, while development of contractions was similar to that seen following vaginal administration...
  45. ncbi Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects
    O S Tang
    Department of Obstetrics and Gynaecology, University of Hong Kong, Hong Kong SAR, China
    Int J Gynaecol Obstet 99:S160-7. 2007
    ..These studies can help to discover the optimal dose and route of administration of misoprostol for individual clinical applications. Misoprostol is a safe drug but serious complications and teratogenicity can occur with unsupervised use...
  46. ncbi Effects of slow release misoprostol on uterine contractility in early pregnancy
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Stockholm, Sweden
    Hum Reprod 20:2648-52. 2005
    ..CONCLUSIONS: SR misoprostol acts less on uterine tonus than orally administered conventional misoprostol but leads to development of regular uterine contractions...
  47. ncbi Treatment of incomplete abortion and miscarriage with misoprostol
    J Blum
    Gynuity Health Projects, New York, NY 10010, USA
    Int J Gynaecol Obstet 99:S186-9. 2007
    ..A single dose of misoprostol 600 microg oral is recommended for treatment of incomplete abortion in women presenting with a uterine size equivalent to 12 weeks gestation...
  48. ncbi Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparison
    A Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institute, S-171 76 Stockholm, Sweden
    Contraception 69:165-9. 2004
    ..It was shown that sublingual administration is more effective than oral administration of misoprostol for cervical priming and is associated with less blood loss but a higher frequency of side effects...
  49. ncbi Pharmacokinetics of a novel oral slow-release form of misoprostol
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
    Hum Reprod 20:3414-8. 2005
    ..The pharmacokinetics of a novel slow-release (SR) misoprostol was studied and compared to conventional misoprostol...
  50. ncbi The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13-22 weeks gestation
    C Fiala
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Clinical Epidemiology Unit, Karolinska Institute, 171 76 Stockholm, Sweden
    Hum Reprod 20:3072-7. 2005
    ....
  51. ncbi Home use of two doses of misoprostol after mifepristone for medical abortion: a pilot study in Sweden and France
    W H Clark
    Gynuity Health Projects, New York, USA
    Eur J Contracept Reprod Health Care 10:184-91. 2005
    ..Further research to determine if two doses of misoprostol are more effective than a single dose would be useful...
  52. ncbi Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol
    A Aronsson
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska University Hospital, Karolinska Institutet, SE 171 76 Stockholm, Sweden
    Hum Reprod 22:1912-8. 2007
    ..No study has so far evaluated the pharmacokinetics beyond 6 hours. Furthermore a new slow-release misoprostol formulation was included in the study...
  53. ncbi Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial
    I Sääv
    Department of Woman and Child Health, Division for Obstetrics and Gynaecology, Karolinska Institutet, S 171 76 Stockholm, Sweden
    Hum Reprod 22:2647-52. 2007
    ..However, insertion of an IUD through a narrow cervix may be technically difficult. Misoprostol has been shown to be effective for cervical priming in non-pregnant women prior to hysteroscopy...
  54. ncbi Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks
    P C Ho
    Department of Obstetrics and Gynaecology, University of Hong Kong, Hong Kong Special Administrative Region, China
    Int J Gynaecol Obstet 99:S178-81. 2007
    ..Common side effects of misoprostol-induced termination of pregnancy include gastrointestinal side effects, abdominal cramps, bleeding, fever and chills. Complications may include infection or rarely rupture of uterus...
  55. ncbi Misoprostol to treat missed abortion in the first trimester
    K Gemzell-Danielsson
    Department of Woman and Child Health, Division of Obstetrics and Gynecology, Karolinska Institutet Karolinska University Hospital, Stockholm, Sweden
    Int J Gynaecol Obstet 99:S182-5. 2007
    ..Bleeding may last for more than 14 days with additional days of light bleeding or spotting. The woman should be advised to contact a provider in case of heavy bleeding or signs of infection. A follow-up is recommended after 1 to 2 weeks...
  56. ncbi Cervical priming with misoprostol prior to transcervical procedures
    C Fiala
    Gynmed Clinic, Vienna, Austria
    Int J Gynaecol Obstet 99:S168-71. 2007
    ..Higher doses or longer intervals do not improve the effect on the cervix. Pain is a frequent side effect, but usually responds well to NSAIDs. Other side effects are rare...
  57. ncbi Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services
    R J Gomperts
    Women on Waves, Amsterdam, The Netherlands
    BJOG 115:1171-5; discussion 1175-8. 2008
    ..8% of the women who did the medical TOP at home needed a vacuum aspiration. Telemedicine can provide an alternative to unsafe TOP. Outcomes of care are in the same range as TOP provided in outpatient settings...